Total Payments
$23,852
2024 Payments
$783.59
Companies
45
Transactions
315
Medicare Patients
4,509
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$13,367 (56.0%)
Food & Beverage$5,656 (23.7%)
Research$4,250 (17.8%)
Travel$499.43 (2.1%)
Education$78.43 (0.3%)
Gifts$1.77 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,367 | 5 | 56.0% |
| Food and Beverage | $5,656 | 299 | 23.7% |
| Unspecified | $4,250 | 2 | 17.8% |
| Travel and Lodging | $499.43 | 2 | 2.1% |
| Education | $78.43 | 6 | 0.3% |
| Gift | $1.77 | 1 | 0.0% |
Payments by Type
General
$19,602
313 transactions
Research
$4,250
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $7,527 | 14 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $6,667 | 12 | $0 (2024) |
| Keryx Biopharmaceuticals, Inc. | $4,385 | 14 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $914.99 | 56 | $0 (2024) |
| Amgen Inc. | $689.91 | 33 | $0 (2024) |
| Janssen Biotech, Inc. | $606.71 | 40 | $0 (2023) |
| Relypsa, Inc. | $250.18 | 14 | $0 (2019) |
| PFIZER INC. | $189.43 | 7 | $0 (2023) |
| GENZYME CORPORATION | $184.54 | 2 | $0 (2018) |
| Radius Health, Inc. | $177.48 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $783.59 | 39 | ANI Pharmaceuticals, Inc. ($146.58) |
| 2023 | $993.71 | 44 | AstraZeneca Pharmaceuticals LP ($212.36) |
| 2022 | $7,052 | 31 | Bayer HealthCare Pharmaceuticals Inc. ($6,569) |
| 2021 | $79.63 | 4 | Aurinia Pharma U.S., Inc. ($42.62) |
| 2020 | $133.46 | 9 | Amgen Inc. ($47.10) |
| 2019 | $839.60 | 47 | AstraZeneca Pharmaceuticals LP ($173.04) |
| 2018 | $8,527 | 66 | Mallinckrodt LLC ($7,457) |
| 2017 | $5,443 | 75 | Keryx Biopharmaceuticals, Inc. ($4,333) |
All Payment Transactions
315 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Bone Health | ||||||
| 11/21/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $1.75 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/20/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/20/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Nephrology | ||||||
| 11/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Bone Health | ||||||
| 11/07/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $33.54 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: DIABETES | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Immunology | ||||||
| 10/31/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/31/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $0.69 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: DIABETES | ||||||
| 10/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Cardio-renal | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/23/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 09/17/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Nephrology | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $30.19 | General |
| Category: Immunology | ||||||
| 08/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Bone Health | ||||||
| 08/21/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $0.94 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 08/20/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 08/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Cardio-renal | ||||||
| 07/29/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Endocrinology | ||||||
| 07/22/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Compass | Keryx Biopharmaceuticals, Inc. | $4,250 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 854 | 1,899 | $1.4M | $244,797 |
| 2022 | 12 | 971 | 2,041 | $1.4M | $246,365 |
| 2021 | 15 | 1,270 | 2,573 | $1.7M | $304,902 |
| 2020 | 15 | 1,414 | 2,915 | $1.9M | $310,293 |
Total Patients
4,509
Total Services
9,428
Medicare Billing
$1.1M
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 46 | 253 | $352,429 | $69,793 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 281 | 611 | $318,942 | $56,654 | 17.8% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 16 | 108 | $125,928 | $24,085 | 19.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 30 | 96 | $112,224 | $21,794 | 19.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 142 | 335 | $119,260 | $20,763 | 17.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 107 | 224 | $115,136 | $20,224 | 17.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 69 | 74 | $73,852 | $10,058 | 13.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 48 | $33,792 | $6,699 | 19.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $39,102 | $5,869 | 15.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 35 | 36 | $24,264 | $3,666 | 15.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 31 | 49 | $17,493 | $2,633 | 15.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 15 | 16 | $21,456 | $2,561 | 11.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 418 | 807 | $421,254 | $70,140 | 16.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 35 | 231 | $321,783 | $64,490 | 20.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 24 | 134 | $156,646 | $30,567 | 19.5% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 14 | 101 | $117,766 | $23,360 | 19.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 121 | 212 | $108,968 | $16,780 | 15.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 137 | 288 | $102,528 | $15,894 | 15.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 44 | 46 | $45,908 | $7,034 | 15.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $39,900 | $5,839 | 14.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 36 | 43 | $28,982 | $4,484 | 15.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 33 | 67 | $23,919 | $3,801 | 15.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 45 | $15,930 | $2,034 | 12.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 17 | $11,968 | $1,942 | 16.2% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 59 | 432 | $601,776 | $120,289 | 20.0% |
About Dr. Prashant Kumar, M.D
Dr. Prashant Kumar, M.D is a Specialist healthcare provider based in Lufkin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427087071.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Prashant Kumar, M.D has received a total of $23,852 in payments from pharmaceutical and medical device companies, with $783.59 received in 2024. These payments were reported across 315 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($13,367).
As a Medicare-enrolled provider, Kumar has provided services to 4,509 Medicare beneficiaries, totaling 9,428 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Lufkin, TX
- Active Since 07/03/2006
- Last Updated 03/17/2011
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1427087071
Products in Payments
- ACTHAR (Biological) $7,601
- Kerendia (Drug) $6,667
- Auryxia (Drug) $4,412
- SIMPONI ARIA (Biological) $412.42
- Veltassa (Drug) $358.11
- FARXIGA (Drug) $345.74
- LOKELMA (Drug) $299.32
- EVENITY (Biological) $239.19
- STELARA (Biological) $238.51
- BYDUREON (Drug) $190.54
- KEVZARA (Drug) $184.54
- Parsabiv (Biological) $160.94
- Tymlos (Biological) $158.71
- PURIFIED CORTROPHIN GEL (Drug) $146.58
- KRYSTEXXA (Biological) $137.31
- JARDIANCE (Drug) $134.84
- LUPKYNIS (Drug) $115.06
- PREVNAR 20 (Biological) $113.85
- SAMSCA (Drug) $102.88
- TARPEYO (Drug) $98.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Lufkin
Mr. Imran Nazeer, M.d, M.D
Specialist — Payments: $4,697
Specialist $4,697
Alan Bassin, Md, MD
Specialist — Payments: $3,911
Specialist $3,911
Dr. George Newton, M.d, M.D
Specialist — Payments: $24.87
Specialist $24.87
Mr. Michael Waters, Lat, Atc, Cscs, LAT, ATC, CSCS
Specialist
Specialist
Edward Domingue, M.d, M.D
Specialist
Specialist
Dr. Francisco Cardenas, Md, MD
Specialist
Specialist